High-yield overview
The Hypermobility Syndromes
13+ SubtypesTypes
Most CommonhEDS
Life-threateningVascular EDS
greater than 4/9Beighton Score
Major EDS Types
Hypermobile (hEDS)
PatternMost common. Joint instability.
TreatmentPhysio, pain management
Classical
PatternSkin hyperextensibility, scarring.
TreatmentWound care, avoidance
Vascular
PatternCOL3A1. Arterial rupture.
TreatmentAvoid surgery, surveillance
Kyphoscoliotic
PatternSevere scoliosis, hypotonia.
TreatmentScoliosis surgery if needed
Critical Must-Knows
- Hypermobile EDS: Most common. Joint instability, chronic pain.
- Vascular EDS: COL3A1 mutation. Arterial rupture risk.
- Beighton Score: Quantifies hypermobility (greater than 4/9).
- Skin: Hyperextensible, easy bruising, poor healing.
- Surgery Caution: Poor tissue healing.
Clinical Pearls
- "Beighton score for hypermobility
- "Vascular EDS is dangerous
- "Surgery has poor healing
- "Chronic pain is common
Clinical Imaging
Imaging Gallery
Vascular EDS
Vascular EDS (COL3A1 mutation) is DANGEROUS.
- Risk of arterial rupture, bowel perforation.
- AVOID invasive procedures if possible.
- Median life expectancy reduced (40-50 years).
- Genetic testing before major surgery.
EDS Types
| Type | Gene/Inheritance | Key Features |
|---|---|---|
| Unknown gene/AD | Most common, joint instability, pain | |
| COL5A1/AD | Skin hyperextensibility, scarring | |
| COL3A1/AD | Arterial rupture, thin skin | |
| PLOD1/AR | Severe scoliosis, hypotonia |
Mnemonic
PTEKFBeighton Score
| P | Pinky Extension greater than 90° (1 each) |
| T | Thumb to Forearm 1 each |
| E | Elbow Hyperextension greater than 10° (1 each) |
| K | Knee Hyperextension greater than 10° (1 each) |
| F | Forward Flexion Palms to floor (1) |
| P | Pinky Extension greater than 90° (1 each) | K | Knee Hyperextension greater than 10° (1 each) |
| T | Thumb to Forearm 1 each | F | Forward Flexion Palms to floor (1) |
| E | Elbow Hyperextension greater than 10° (1 each) |
Hook:PTEKF - Pinky, Thumb, Elbow, Knee, Forward flex. Total 9 points.
Mnemonic
EDS FEDS Features
| H | Hypermobility Joints |
| S | Skin Hyperextensible, fragile |
| P | Pain Chronic |
| D | Dislocations Recurrent |
| H | Hypermobility Joints | P | Pain Chronic |
| S | Skin Hyperextensible, fragile | D | Dislocations Recurrent |
Hook:HSPD - Hypermobility, Skin, Pain, Dislocations.
Mnemonic
EDS RVascular EDS Red Flags
| T | Thin skin Translucent, visible veins |
| R | Rupture risk Arterial, bowel |
| A | Avoid surgery If possible |
| P | Poor prognosis Median 40-50 years |
| T | Thin skin Translucent, visible veins | A | Avoid surgery If possible |
| R | Rupture risk Arterial, bowel | P | Poor prognosis Median 40-50 years |
Hook:TRAP - Thin skin, Rupture, Avoid surgery, Poor prognosis.
Mnemonic
CAREEDS Surgical Precautions
| C | Careful tissue handling Tissue is fragile and heals poorly |
| A | Avoid tension Use tension-free closure techniques |
| R | Reinforce repairs Use augmentation for ligament surgery |
| E | Expect complications Higher wound healing, infection rates |
| C | Careful tissue handling Tissue is fragile and heals poorly | R | Reinforce repairs Use augmentation for ligament surgery |
| A | Avoid tension Use tension-free closure techniques | E | Expect complications Higher wound healing, infection rates |
Hook:Take CARE with EDS patients - surgery outcomes are less predictable!
Overview/Epidemiology
Ehlers-Danlos Syndrome (EDS) is a group of connective tissue disorders.
- Genetics: Multiple types with different genes. Most autosomal dominant.
- Prevalence: 1 in 5,000 (hEDS more common).
- Pathophysiology: Defects in collagen or proteins that interact with collagen.
Pathophysiology, Anatomy and Pathomechanics
Collagen Abnormalities
- Different types affect different collagen genes.
- Leads to weak ligaments, skin, blood vessels.
Why Joint Instability Occurs
- Ligaments are lax and cannot stabilize joints.
- Recurrent subluxations and dislocations.
- Chronic pain from microtrauma and joint damage.
Classification Systems
Hypermobile EDS (hEDS)
- Most common type.
- Unknown gene (clinical diagnosis).
- Generalized joint hypermobility (Beighton greater than 4/9 in adults or 5/9 in children).
- Chronic pain, fatigue.
- Joint instability, dislocations.
Clinical Assessment
History:
- Joint dislocations/subluxations.
- Chronic pain, fatigue.
- Easy bruising.
- Wound healing problems.
- Family history.
Physical Exam:
- Beighton Score: Assess hypermobility.
- Skin: Hyperextensibility, texture, scars.
- Joints: Instability, signs of previous dislocations.
Investigations
Clinical Diagnosis:
- hEDS is diagnosed clinically (no genetic test available).
Genetic Testing:
- Classical, Vascular, and other types can be confirmed genetically.
- Consider vascular EDS testing before major surgery if suspected.
Management Algorithm
Conservative Management
- Physiotherapy: Strengthen muscles around joints to provide stability.
- Pain Management: Multimodal approach.
- Activity Modification: Avoid hyperextension, high-impact activities.
- Bracing: For unstable joints.
Surgical Techniques
Joint Stabilization
Indications: Recurrent dislocations (shoulder, patella).
Technique: Standard stabilization procedures (Bankart, MPFL, etc.).
Considerations: Use stronger fixation, cautious tissue handling. Expect higher recurrence. Prolonged immobilization may help.
Complications
| Complication | Context | Management |
|---|---|---|
| Wound Dehiscence | Poor healing | Meticulous closure, sutures longer |
| Recurrent Instability | Surgery failure | Accept higher failure rate |
| Chronic Pain | Disease-related | Multimodal pain management |
| Arterial Rupture | Vascular EDS | Avoid procedures |
Postoperative Care
- Extended Immobilization: Tissues need longer to heal.
- Careful Suturing: Leave sutures longer.
- Physiotherapy: Gradual, cautious.
Outcomes/Prognosis
- hEDS: Normal lifespan but chronic symptoms.
- Vascular EDS: Reduced life expectancy (arterial rupture).
- Surgical Outcomes: Higher failure rate than general population.
Controversies & Areas of Uncertainty
- The hEDS / HSD boundary: hEDS still has no identified gene and is diagnosed by clinical criteria alone. The distinction from hypermobility spectrum disorder (HSD) is debated, and many "hEDS" patients meet HSD rather than strict 2017 criteria — management is the same.
- Paediatric diagnosis: A higher Beighton cut-off (the 2023 international paediatric framework proposes greater than or equal to 6/9) better identifies true hypermobility in children, and the label hEDS is reserved for biologically mature adolescents.
- Surgical decision-making: There is no high-level evidence on whether stabilisation procedures (e.g. shoulder, patellofemoral) durably outperform sustained rehabilitation in EDS; higher recurrence is consistently reported but optimal patient selection is unclear.
- Celiprolol generalisability: Benefit was shown mainly in COL3A1-confirmed and clinically diagnosed vascular EDS in a small trial; its value in mutation-negative phenotypes and in non-vascular subtypes is unproven.
- Pain mechanisms: Chronic pain in hEDS is increasingly attributed to central sensitisation and dysautonomia rather than joint laxity alone, shifting management toward multimodal and neuromodulatory approaches.
Evidence Base
2017 International Classification of the Ehlers-Danlos Syndromes
Malfait F, Francomano C, Byers P, et al. (International EDS Consortium) • Am J Med Genet C Semin Med Genet (2017)
Key Findings:
- Replaced the 1998 Villefranche Nosology (6 subtypes) with 13 recognised EDS subtypes, each with a set of suggestive clinical criteria.
- Definitive diagnosis of every subtype EXCEPT hypermobile EDS now requires molecular confirmation of a causative variant.
- Revised hEDS criteria were introduced specifically to separate hEDS from other joint hypermobility disorders (HSD).
Clinical Implication: Use the 2017 classification as the diagnostic standard; do not rely on the old Villefranche types.
Clinical and Genetic Features of EDS Type IV (Vascular Type) — Landmark Cohort
Pepin M, Schwarze U, Superti-Furga A, Byers PH • N Engl J Med (2000)
Key Findings:
- Cohort of 220 index patients plus 199 affected relatives with biochemically confirmed vascular EDS; calculated median survival was 48 years.
- Complications were rare in childhood — 25% had a first major complication by age 20 and over 80% by age 40; most deaths were from arterial rupture.
- Bowel rupture (often sigmoid) caused about a quarter of complications; 12 of 81 women who became pregnant died from pregnancy-related complications.
Clinical Implication: Vascular EDS shortens life expectancy and warrants surveillance, an emergency plan and avoidance of elective invasive procedures.
Celiprolol Prevents Arterial Events in Vascular EDS (BBEST Trial)
Ong KT, Perdu J, De Backer J, et al. • Lancet (2010)
Key Findings:
- Multicentre randomised, open, blinded-endpoint trial; 53 patients (33 COL3A1-positive) assigned to celiprolol or no treatment.
- Primary arterial events occurred in 5/25 (20%) on celiprolol versus 14/28 (50%) controls (HR 0.36, 95% CI 0.15-0.88, p=0.040); the trial was stopped early for benefit.
- Celiprolol, a beta-1 antagonist with beta-2 agonist action, was well tolerated (fatigue the main adverse effect).
Clinical Implication: Celiprolol is the best-evidenced pharmacological measure to reduce arterial rupture/dissection in vascular EDS.
Diagnosis, Natural History and Management of Vascular EDS — International Consensus
Byers PH, Belmont J, Black J, et al. • Am J Med Genet C Semin Med Genet (2017)
Key Findings:
- Estimated frequency 1/50,000 to 1/200,000; recommends confirming a COL3A1 variant before applying the diagnosis.
- Advises a vascular EDS 'passport' for emergencies, management at centres of excellence, aggressive blood-pressure control and annual non-invasive vascular surveillance (duplex/CTA/MRA).
- Surgery should be minimised; when unavoidable, tissue handling must be exceptionally gentle.
Clinical Implication: Frames the modern multidisciplinary, surveillance-based care pathway for vascular EDS.
Musculoskeletal Complaints, Activity and Quality of Life in Hypermobile EDS
Rombaut L, Malfait F, Cools A, De Paepe A, Calders P • Disabil Rehabil (2010)
Key Findings:
- 32 women with hEDS versus 32 matched controls; joint pain was the most frequent and most severe symptom, with significantly more dislocations, cramps, tendinitis and fatigue.
- Habitual physical activity (particularly sport) and all eight RAND-36 quality-of-life domains were significantly reduced in hEDS.
- Demonstrates the heavy musculoskeletal and psychosocial burden that drives the need for structured rehabilitation.
Clinical Implication: Supports physiotherapy-led, multimodal conservative management as the foundation of hEDS care.
Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
CLINICAL SCENARIOStandard
Recurrent Shoulder Dislocations
CLINICAL PROMPT
"20-year-old female with recurrent anterior shoulder dislocations. Beighton score 8/9. Easy bruising. How do you manage?"
PRACTICAL APPROACH
This patient likely has **hypermobile EDS** given the high Beighton score and easy bruising. Management: First-line is **conservative** - physiotherapy to strengthen rotator cuff and scapular stabilizers, activity modification, bracing. If surgery is needed, I would counsel about **higher failure rates** due to poor tissue quality. I would use stronger fixation techniques and prolonged post-op immobilization. I would also consider genetic testing to exclude vascular EDS before surgery.
KEY CLINICAL POINTS
Consider EDS in hypermobile patients
Conservative first
Surgery has higher failure
COMMON PITFALLS
Not recognizing EDS
Not counseling about higher failure
FURTHER QUESTIONS
"What is the Beighton score?"
CLINICAL SCENARIOStandard
Vascular EDS Screening
CLINICAL PROMPT
"Same patient mentions her mother died of arterial rupture at age 45. What do you do now?"
PRACTICAL APPROACH
This raises concern for **vascular EDS** (COL3A1 mutation), which has autosomal dominant inheritance. Arterial rupture is a major feature. I would **not proceed with elective surgery** until this is excluded. I would refer for **genetic testing** for vascular EDS. If confirmed, invasive procedures should be avoided if possible. The patient would need regular surveillance and genetic counseling.
KEY CLINICAL POINTS
Vascular EDS is dangerous
Genetic testing before surgery
Avoid invasive procedures
COMMON PITFALLS
Proceeding with surgery
Not considering family history
FURTHER QUESTIONS
"What gene is mutated in vascular EDS?"
CLINICAL SCENARIOStandard
Beighton Score
CLINICAL PROMPT
"How do you assess the Beighton Score?"
PRACTICAL APPROACH
The **Beighton Score** assesses generalized joint hypermobility. It has **9 points**: (1) Little finger extension over 90° - 1 point each side. (2) Thumb to forearm - 1 point each side. (3) Elbow hyperextension over 10° - 1 point each side. (4) Knee hyperextension over 10° - 1 point each side. (5) Palms flat on floor with knees straight - 1 point. Score **over 4/9 in adults** (or over 5/9 in children) indicates generalized hypermobility.
KEY CLINICAL POINTS
9 point score
greater than 4/9 positive
Assesses hypermobility
COMMON PITFALLS
Not knowing the maneuvers
FURTHER QUESTIONS
"What are the EDS types?"
MCQ Practice Points
Type MCQ
Q: Which EDS type is most common? A: Hypermobile EDS (hEDS).
Dangerous MCQ
Q: Which EDS type has the highest mortality? A: Vascular EDS (COL3A1) - arterial rupture.
Assessment MCQ
Q: What score assesses hypermobility? A: Beighton Score (over 4/9 in adults).
Surgery MCQ
Q: What is a concern with surgery in EDS? A: Poor tissue healing, higher recurrence rates.
Genetics Pearl
Q: What gene is mutated in vascular EDS? A: COL3A1 (Type III collagen). This causes arterial rupture, bowel perforation, and thin translucent skin.
Diagnosis Pearl
Q: How is hEDS different from other EDS types for diagnosis? A: hEDS has no genetic test - it is diagnosed clinically. All other EDS types can be confirmed with genetic testing.
Guidelines, Registries & Global Practice
Global epidemiology
- All EDS types combined: roughly 1 in 5,000. Hypermobile EDS / hypermobility spectrum disorders dominate (the large majority of cases).
- Vascular EDS is rare: 1 in 50,000 to 1 in 200,000 (Byers et al, 2017).
- hEDS shows a marked female predominance in clinic populations; rare recessive types (kyphoscoliotic, dermatosparaxis) cluster in consanguineous populations.
Side-by-side guidance
| Body | Position |
|---|---|
| International EDS Consortium (2017) | Single global standard: 13 subtypes; molecular confirmation for all types except hEDS; revised hEDS criteria |
| Ehlers-Danlos Society | Maintains the consortium criteria, the vascular EDS "passport" and emergency-care guidance; international patient registry |
| vEDS consensus (Byers 2017) | Confirm COL3A1, manage at centres of excellence, aggressive BP control, annual non-invasive vascular surveillance, minimise surgery |
| Cardiology bodies (ESC/ACC) | Vascular EDS managed within heritable thoracic aortic/connective-tissue disease pathways; celiprolol where available |
There is no orthopaedic implant registry signal specific to EDS, but registry-style cohort data (e.g. the Pepin NEJM cohort) underpin natural-history estimates, and the international EDS registry is building genotype-phenotype data.
High- vs limited-resource practice
- Well-resourced: gene-panel/exome testing, MDT (genetics, rheumatology, cardiology, physiotherapy, pain), celiprolol for vascular EDS, annual cross-sectional vascular imaging.
- Limited-resource: diagnosis remains largely clinical (Beighton score, skin and family history); prioritise physiotherapy, activity advice and recognition of vascular EDS red flags for urgent referral when genetic testing and celiprolol are unavailable.
EHLERS-DANLOS SYNDROME
Clinical summary
TYPES
- •hEDS: Most common
- •Classical: Skin
- •Vascular: Dangerous
- •Kyphoscoliotic: Scoliosis
FEATURES
- •Hypermobility
- •Skin hyperextensibility
- •Dislocations
- •Chronic pain
BEIGHTON SCORE
- •Pinky, Thumb, Elbow
- •Knee, Forward flex
- •9 points total
- •greater than 4/9 = positive
SURGERY
- •Higher failure
- •Poor healing
- •Avoid in vascular EDS
- •Conservative first
VASCULAR EDS
- •COL3A1 mutation
- •Arterial rupture
- •Bowel perforation
- •Median survival 40-50 years
KEY GENES
- •hEDS: Unknown
- •Classical: COL5A1
- •Vascular: COL3A1
- •Kyphoscoliotic: PLOD1
Self-Assessment Quiz
Differential Diagnosis
Hypermobility Spectrum Disorders:
| Condition | Key Features | Differentiator |
|---|---|---|
| Hypermobile EDS | Joint instability, pain | Beighton positive, clinical dx |
| Benign Joint Hypermobility | Hypermobility only | No systemic features |
| Marfan Syndrome | Tall, aortic root | FBN1 mutation, lens UP |
| Loeys-Dietz | Bifid uvula | TGFBR1/2 |
| Osteogenesis Imperfecta | Fragile bones | COL1A1/2, blue sclerae |
Key Distinguishing Points:
- EDS: Skin AND joint involvement, chronic pain
- Marfan: Cardiovascular focus, tall thin habitus
- OI: Bone fragility primary (fractures)
- Benign hypermobility: Hypermobility only, no pain syndrome